Nicole LaBrosse - Feb 10, 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 10, 2023
Transactions value $
-$101,411
Form type
4
Date filed
2/14/2023, 04:21 PM
Previous filing
Nov 16, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +2.5K +61.88% $0.00 6.55K Feb 10, 2023 Direct
transaction HALO Common Stock Tax liability -$68.1K -1.39K -21.26% $48.92 5.16K Feb 10, 2023 Direct F1
transaction HALO Common Stock Options Exercise $0 +1.39K +26.94% $0.00 6.55K Feb 12, 2023 Direct
transaction HALO Common Stock Tax liability -$33.3K -681 -10.4% $48.92 5.86K Feb 12, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -2.5K -50.01% $0.00 2.5K Feb 10, 2023 Common Stock 2.5K $0.00 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -1.39K -100% $0.00* 0 Feb 12, 2023 Common Stock 1.39K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 1,392 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F2 The reported disposition of 681 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.